Skip to content

Achieve Life Sciences, Inc.

ACHV· NasdaqCore metricsCIK 949858

In vitro & in vivo diagnostic substances19 peers

Last sale
Nov 9, 2026 · +1.19%
Market cap
$746.48M
109.78M shares
Filings
1,034
$0.00
FY 2019
-$12.11M
Q3 2026N/M FY25 yoy
$8.29M
Q3 2012
—
-$26.12M
Q3 2026derivedN/M FY25 yoy
-$0.11
Q3 2026N/M FY25 yoy
$59.74M
Q3 2026+64.1% FY25 yoy
$746.48M
—
—
4.1×
-6.63%
—

FY2025 figures · derived

Price

$6.80+53.50%+$2.37past year
Nov 9, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2019
$0.000FY 2018FY 2019
PeriodEndedValueKindSource trail
FY 20192019-12-31$0reported
FY 20182018-12-31$0reported

In vitro & in vivo diagnostic substances

Achieve Life Sciences, Inc. is the 8th largest of the 20 covered companies the SEC files under this code, by total assets. SIC 2835

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in total assets first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR